NASDAQ:TLPH Talphera (TLPH) Stock Price, News & Analysis $0.99 -0.02 (-1.98%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.96▼$1.0450-Day Range$0.85▼$1.0752-Week Range$0.43▼$1.61Volume44,194 shsAverage Volume88,232 shsMarket Capitalization$16.82 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Talphera alerts: Email Address Talphera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside354.5% Upside$4.50 Price TargetShort InterestHealthy0.53% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$5,411 Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($0.73) to ($1.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.94 out of 5 starsMedical Sector551st out of 910 stocksPharmaceutical Preparations Industry256th out of 426 stocks 3.5 Analyst's Opinion Consensus RatingTalphera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageTalphera has only been the subject of 1 research reports in the past 90 days.Read more about Talphera's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.53% of the float of Talphera has been sold short.Short Interest Ratio / Days to CoverTalphera has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talphera has recently decreased by 35.48%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalphera does not currently pay a dividend.Dividend GrowthTalphera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TLPH. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Talphera this week, compared to 7 articles on an average week.Search InterestOnly 5 people have searched for TLPH on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.MarketBeat Follows3 people have added Talphera to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talphera insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,411.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 3.00% of the stock of Talphera is held by insiders.Percentage Held by InstitutionsOnly 37.67% of the stock of Talphera is held by institutions.Read more about Talphera's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Talphera are expected to decrease in the coming year, from ($0.73) to ($1.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talphera is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talphera is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalphera has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Talphera's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Talphera Stock (NASDAQ:TLPH)Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.Read More TLPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TLPH Stock News HeadlinesSeptember 5 at 4:15 PM | prnewswire.comTalphera to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 19, 2024 | prnewswire.comTalphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal CircuitSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 16, 2024 | markets.businessinsider.comBullish Outlook on Talphera’s Niyad: Phase 3 Trial Advancements and Market Potential Justify Buy RatingAugust 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Talphera Amid Strategic Advancements in NEPHRO CRRT StudyAugust 15, 2024 | seekingalpha.comTalphera, Inc. (TLPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | finanznachrichten.deTalphera, Inc.: Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | sfgate.comTalphera: Q2 Earnings SnapshotSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 15, 2024 | msn.comTalphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | markets.businessinsider.comTLPH Stock Earnings: Talphera Beats EPS for Q2 2024August 14, 2024 | prnewswire.comTalphera Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 5, 2024 | prnewswire.comTalphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024May 20, 2024 | prnewswire.comTalphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 17, 2024 | msn.comTalphera, Inc. (NASDAQ:TLPH) Q1 2024 Earnings Call TranscriptMay 16, 2024 | markets.businessinsider.comOptimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment DelayMay 16, 2024 | prnewswire.comTalphera to Participate at A.G.P. Virtual Healthcare ConferenceMay 15, 2024 | finance.yahoo.comTalphera Inc (TLPH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...See More Headlines Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2024Today9/07/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TLPH Previous SymbolNASDAQ:TLPH CUSIPN/A CIK1427925 Webtalphera.com Phone650-216-3500Fax650-216-6500Employees19Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+354.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,400,000.00 Net MarginsN/A Pretax Margin-3,443.97% Return on Equity-88.77% Return on Assets-56.10% Debt Debt-to-Equity RatioN/A Current Ratio4.90 Quick Ratio4.90 Sales & Book Value Annual Sales$398,000.00 Price / Sales42.27 Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book1.32Miscellaneous Outstanding Shares16,993,000Free Float16,483,000Market Cap$16.82 million OptionableOptionable Beta0.33 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Vincent J. Angotti (Age 56)CEO & Director Comp: $906.54kDr. Pamela Pierce Palmer M.D. (Age 61)Ph.D., Co-Founder & Chief Medical Officer Comp: $699.75kMr. Raffi Mark Asadorian (Age 55)Chief Financial Officer Comp: $637.5kMr. Anil N. Dasu (Age 61)Chief Engineering Officer Comp: $478.09kKey CompetitorsEntera BioNASDAQ:ENTXRAPT TherapeuticsNASDAQ:RAPTJATT AcquisitionNYSE:JATTSonoma PharmaceuticalsNASDAQ:SNOAVor BiopharmaNYSE:VORView All CompetitorsInsiders & InstitutionsNantahala Capital Management LLCBought 1,992,519 shares on 8/20/2024Ownership: 11.726%Turtle Creek Wealth Advisors LLCBought 71,500 shares on 7/31/2024Ownership: 0.421%Vincent J AngottiBought 1,304 shares on 6/14/2024Total: $1,408.32 ($1.08/share)Vincent J AngottiBought 4,126 shares on 6/12/2024Total: $4,002.22 ($0.97/share)View All Insider TransactionsView All Institutional Transactions TLPH Stock Analysis - Frequently Asked Questions How have TLPH shares performed this year? Talphera's stock was trading at $0.7989 at the start of the year. Since then, TLPH shares have increased by 23.9% and is now trading at $0.99. View the best growth stocks for 2024 here. How were Talphera's earnings last quarter? Talphera, Inc. (NASDAQ:TLPH) announced its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.07. Who are Talphera's major shareholders? Top institutional shareholders of Talphera include Nantahala Capital Management LLC (11.73%) and Turtle Creek Wealth Advisors LLC (0.42%). View institutional ownership trends. How do I buy shares of Talphera? Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TLPH) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPH Stock Alerts